Deutsche Bank’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-35,472
| Closed | -$12K | – | 5303 |
|
|
2016
Q3 | $12K | Buy |
35,472
+7,427
| +26% | +$2.51K | ﹤0.01% | 4644 |
|
|
2016
Q2 | $13K | Sell |
28,045
-34
| -0.1% | -$16 | ﹤0.01% | 4873 |
|
|
2016
Q1 | $37K | Sell |
28,079
-12,311
| -30% | -$16.2K | ﹤0.01% | 4427 |
|
|
2015
Q4 | $58K | Sell |
40,390
-9,597
| -19% | -$13.8K | ﹤0.01% | 4333 |
|
|
2015
Q3 | $78K | Buy |
49,987
+5,699
| +13% | +$8.89K | ﹤0.01% | 4213 |
|
|
2015
Q2 | $74K | Buy |
44,288
+34,469
| +351% | +$57.6K | ﹤0.01% | 4399 |
|
|
2015
Q1 | $12K | Buy |
9,819
+4,746
| +94% | +$5.8K | ﹤0.01% | 4779 |
|
|
2014
Q4 | $7K | Sell |
5,073
-1,057
| -17% | -$1.46K | ﹤0.01% | 5821 |
|
|
2014
Q3 | $12K | Sell |
6,130
-41,849
| -87% | -$81.9K | ﹤0.01% | 5359 |
|
|
2014
Q2 | $146K | Sell |
47,979
-342,806
| -88% | -$1.04M | ﹤0.01% | 4339 |
|
|
2014
Q1 | $976K | Buy |
390,785
+370,677
| +1,843% | +$926K | ﹤0.01% | 2876 |
|
|
2013
Q4 | $99K | Sell |
20,108
-97,608
| -83% | -$481K | ﹤0.01% | 4065 |
|
|
2013
Q3 | $268K | Buy |
117,716
+67,926
| +136% | +$155K | ﹤0.01% | 3941 |
|
|
2013
Q2 | $109K | Buy |
+49,790
| New | +$109K | ﹤0.01% | 4182 |
|
Deutsche Bank's RXII Position: Q4 2016 in Review
Deutsche Bank sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 35,472 shares — an estimated $12K sold.
Deutsche Bank first reported a position in RXII in Q2 2013 and held it in 14 quarters. The position peaked at $976K in Q1 2014. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.
- Deutsche Bank reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
- Deutsche Bank sold 35,472 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $12K.
- Deutsche Bank first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 14 quarters.
- Deutsche Bank's GALENA BIOPHARMA INC COM position peaked at $976K in Q1 2014.
- 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.
Based on Deutsche Bank's 13F filing for Q4 2016, filed 14 Feb 2017.